Cogent Biosciences (COGT) Cash from Investing Activities Growth (1y) (2018 - 2026)
Cogent Biosciences (COGT) Cash from Investing Activities Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Cogent Biosciences |
5.09 Bn |
4.22 Bn |
- |
-152.55% |
| Date | Value |
|---|
| Mar 31, 2026 |
-152.55% |
| Dec 31, 2025 |
-623.37% |
| Sep 30, 2025 |
-357.61% |
| Jun 30, 2025 |
110.53% |
| Mar 31, 2025 |
6,545.50% |
| Dec 31, 2024 |
487.96% |
| Sep 30, 2024 |
166.48% |
| Jun 30, 2024 |
-8.97% |
| Mar 31, 2024 |
-98.26% |
| Dec 31, 2023 |
-63.08% |
| Sep 30, 2023 |
40.26% |
| Jun 30, 2023 |
-6,688.55% |
| Mar 31, 2023 |
13,679.14% |
| Dec 31, 2022 |
6,661.43% |
| Sep 30, 2022 |
-12,930.44% |
| Dec 31, 2019 |
-100.09% |
| Sep 30, 2019 |
-97.72% |
| Jun 30, 2019 |
119.33% |
| Mar 31, 2019 |
152.32% |
| Dec 31, 2018 |
206.12% |
